• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

    Novartis Invests in Credence MedSystems

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

    Almac Expands Global Biologics Testing Services

    GRAM Makes Major Investment in Additional Advanced Equipment
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    The Future of Pharmaceutical Manufacturing

    Recent Advances in Solid Dispersion Technologies

    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Novartis Invests in Credence MedSystems

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Vaccines 2021

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs

    Business Intelligence For (and From) the Lab

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    PCI Pharma Services

    Aphena Pharma Solutions

    Alcami

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Reed-Lane

    Syngene

    Aphena Pharma Solutions

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    India Frames Guidance for Drug Surveillance

    Outsourcing PV functions to rise

    India Frames Guidance for Drug Surveillance
    Related CONTENT
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • Life Sciences Strive for Greater Agility
    • Inozyme Pharma Appoints SVP, Regulatory Affairs
    • Diamond Pharma Services Supports GenSight Biologics
    • Specialist CRO Expands Pharmacovigilance Capabilities
    S. Harachand, Contributing Editor07.18.17
    The pharmacovigilance sector has received a much-needed booster dose with India finalizing a regulatory roadmap for post marketing surveillance of pharmaceutical products. Central Drugs Standard Control Organization (CDSCO), the office of India’s top regulator, has come out with a draft of revised guidelines for surveillance of safety of pharmaceuticals approved and sold in the market.

    The regulatory agency charted out the document in association with the Indian Pharmacopoeia Commission (IPC), which currently co-ordinates various pharmacovigilance activities across the country. Practices like signal detection, safety updates or risk management etc have not been very common among the Indian firms. Select hospitals and only a small number of companies used to report adverse drug reactions (ADR), as per Phramacovigilance Programme of India (PvPI).

    That is perhaps the reason why the Government of India, in a landmark decision, mandated pharmacovigilance a legal obligation for the pharmaceutical industry through a notification in March last year. It also made compulsory for firms seeking marketing approvals to have pharmcovigilance system, managed by qualified and trained personnel, in place.

    The draft surveillance guidance issued by CDSCO categorizes pharmaceutical products under four broad groups: New drugs, subsequent drugs approved after 4-years; biologics; radiopharmaceuticals and phytopharmaceuticals.  
     
    The focus is on identifying the risks emerging from the use of pharmaceutical products “circulating in the market after post licensure period” and setting up a pharmacovigilance system at the site of importers and manufacturers to mitigate such risks.

    A site-based pharmacovigilance system should be managed with a medical officer or a pharmacist as a pharmacovigilance officer-in-charge (PVOI). This officer will collect and analyse adverse drug reaction reports related to pharmaceutical products marketed by the company in India.

    The PVOI will take care of collation, processing, assessment, reporting and follow-up of individual case safety report (ICSR).

    Marketing authorization holders should submit all ICSRs to National Coordination Centre, Pharmacovigilance Programme of India within the prescribed timelines, in specified electronic format as per the norms stipulated in the Schedule Y of Indian Drugs & Cosmetics Act, 1940 and Rule 1945—the pharma rule book.

    In a system where PVOI is at the center, the officer also looks after detection of signal, corrective and preventive action, preparation and submission of periodic safety update report (PSUR) of new drugs and risk management system for each pharmaceutical product.

    The document enlists training for system staff, framing of standard operating procedures, maintenance of quality management system of pharamacovigilance department are the responsibilities of the PVOI.

    Delineating the roles and responsibilities of regulatory authorities including CDSCO, PvPI at IPC, it recommends that Pharmacovigilance System Master File (PvMF), which will contain all the information pertaining to PV system, shall be located at the site in India where the PV activities are performed.

    Supervision and audits of the PV system need to be carried out by the company’s quality assurance team. Representatives from CDSCO, PvPI and concerned state licensing authority will jointly hold inspections at the place where PV activities are performed to ensure compliance with regulatory obligations.

    Violators will face penal actions ranging from re-inspections to suspension of marketing authorization to delays in approvals of new marketing authorization applications until corrective and preventive actions have been implemented.

    Several companies have already started establishing in-house PV systems in their organizations. While others meet the regulatory obligations through hiring services from pharmacovigilance CROs. The guidance document views contractual partners as “potential source of ICSRs” and recommends to clearly define responsibilities regarding PV activities among partners.

    Meanwhile, CROs discern the regulatory move having a positive impact that will spur the growth of India’s pharmacovigilance outsourcing industry. The trend of roping in CROs for managing Indian pharmacovigilance compliance is more visible since the 2016 order mandating PV cells.

    However, Indian companies with a generic mindset could take some time to understand that global pharmacovigilance obligations are no different for innovators and generic drug makers and to accept pharmacovigilance as an integral part of their system, according to Dr. Venkatraman.

    Evidently, implementation of good pharmacovigilance practices is expected to improve compliance and reduce the current gap in post marketing surveillance and drug safety that exist between India and other tightly regulated markets.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • it
    • training
    • pharmacovigilance
    • biologics
    Suggested For You
    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021 The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility
    Inozyme Pharma Appoints SVP, Regulatory Affairs Inozyme Pharma Appoints SVP, Regulatory Affairs
    Diamond Pharma Services Supports GenSight Biologics Diamond Pharma Services Supports GenSight Biologics
    Specialist CRO Expands Pharmacovigilance Capabilities Specialist CRO Expands Pharmacovigilance Capabilities
    AMRI Bought for $922M AMRI Bought for $922M
    Top Indian Firms Expand Base  in the U.S. Top Indian Firms Expand Base in the U.S.
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Indian Generic Firms  Expand Biosimilar Portfolios Indian Generic Firms Expand Biosimilar Portfolios
    Porton USA Acquires J-STAR Research for $26M Porton USA Acquires J-STAR Research for $26M
    Communicating Occupational Hazards Through Colour Communicating Occupational Hazards Through Colour
    WHO Lauds India’s Vaccine Safety WHO Lauds India’s Vaccine Safety
    Trump Picks New FDA Commish Trump Picks New FDA Commish
    Keapstone Therapeutics and Sygnature Discovery Collaborate Keapstone Therapeutics and Sygnature Discovery Collaborate
    Booster Dose for Device Makers Booster Dose for Device Makers

    Related Columns

    • Biologics, Proteins, Vaccines | Drug Development
      The Future Is… Therapeutic

      The Future Is… Therapeutic

      As cell and gene therapies rise, so too does outsourcing
      Ben Locwin 06.13.19

    • Drug Development | Drug Discovery

      The Trials and Tribulations of Male Contraception

      Where has research led in the search for effective oral male contraception?
      Adele Graham-King, Contributing Editor 03.07.17

    • Analytical Services | Drug Development | Laboratory Testing

      Orphan Drug Development & Production: Turning Lemons into Lemonade

      Forming a “win-win-win” paradigm for large pharma companies, contract service providers and generics
      Emil W. Ciurczak, DoraMaxx Consulting 01.26.17


    • Drug Development | Drug Discovery | R&D

      Taking the Wheeze Out of Asthma

      Novartis’ fevipiprant looks like a promising asthma treatment on the horizon
      Adele Graham-King, Contributing Editor 09.08.16

    • Drug Development | Drug Discovery

      How ‘Mush-room’ For Improvement in Antibiotic Production?

      The medical world is acutely aware of the issues on the horizon with regards to antibiotic resistance
      Adele Graham-King, Contributing Editor 06.02.16

    • Drug Delivery | Drug Development | Excipients | Injectables | Parenterals

      What You Need to Know About Drug Formulation

      Formulation is the part of the drug development process where ideas and concepts become tangible
      Ben Locwin, Contributing Editor 05.05.16


    • Clinical Trials | Drug Development

      Recap of Notable Recent CRO Transactions

      Conditions are expected to remain favorable for M&A and capital markets activity in the pharmaceutical service and IT sector
      Chad Moore 10.07.15

    • Clinical Trials | Drug Development

      Medical Affairs: The Next Wave of Outsourcing?

      Outsourcing of medical affairs is on the rise, creating opportunities for third-party providers
      Chad Moore, Robert W. Baird & Co. Inc. 07.14.15

    • Clinical Trials | Drug Development

      M&A Activity Heats Up

      Last year was hot, but 2015 looks to be hotter.
      Chad Moore, Robert W. Baird & Co. Inc. 01.29.15


    • Clinical Trials | Drug Development

      Quantifying the Value of Time

      Clinical attrition and quality-adjusted life years make for dissatisfied patients
      Ben Locwin, Ph.D., Healthcare Science Advisors 09.08.14

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • 500+ Sites Join Inato’s Industry Marketplace
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    • Novartis Invests in Credence MedSystems
    • Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    • Almac Expands Global Biologics Testing Services
    • GRAM Makes Major Investment in Additional Advanced Equipment
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PepsiCo and Beyond Meat Partner to Develop Plant-Based Protein
    New Study on Sage Extract Formula Suggests Memory Enhancement
    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    Coatings World

    Latest Breaking News From Coatings World

    Mayzo Makes 2 Appointments
    Mississippi Lime Company Announces New Director of Safety
    IFS Coatings Launches IFS Puroplaz PE20 Texture
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spectrum Solutions Collaborates with UCLA School of Dentistry
    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty to Shut Down Manufacturing Site in Cologne, Germany
    L’Occitane Files for Bankruptcy in U.S.
    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    Happi

    Latest Breaking News From Happi

    CLT Introduces Private Label Solid Air Freshener Cones
    The Florida Sunscreen Symposium Is Back!
    TFF Opens Nominations for 2021 Awards
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Georgia-Pacific Acquires 3rd HP PageWide Corrugated Press to Expand Hummingbird Digital Printing
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex acquires MDV Group
    Fix-A-Form eyes global expansion
    McCracken Label installs Fujifilm water-wash plate system
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Nice-Pak Receives EPA Approval for Disinfecting Wipes
    Rockline to Invest $18 Million in Arkansas
    Essity’s Sales Negatively Impacted by Covid-19 Pandemic
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChoiceSpine's Tiger Shark Cervical Spacer Earns Additional 510(k)
    FDA Green Lights Inspired Spine's Trident SI Joint Screw System
    FDA Clears Method to Extract Bone Measurements From X-Rays
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram Sees Jump in Profits in Preliminary 2020 Report
    LG Display Reports 4Q 2020 Results
    Xerox Releases 4Q, Full Year Results

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login